A detailed history of Blackhill Capital Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Blackhill Capital Inc holds 147,398 shares of LLY stock, worth $133 Million. This represents 6.62% of its overall portfolio holdings.

Number of Shares
147,398
Previous 148,423 0.69%
Holding current value
$133 Million
Previous $86.5 Million 32.54%
% of portfolio
6.62%
Previous 6.99%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $607,005 - $812,087
-1,025 Reduced 0.69%
147,398 $115 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $1.73 Million - $2.04 Million
3,290 Added 2.27%
148,423 $86.5 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $86,940 - $119,859
-200 Reduced 0.14%
145,133 $78 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $105,222 - $140,694
-300 Reduced 0.21%
145,333 $68.2 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $465,945 - $547,230
-1,500 Reduced 1.02%
145,633 $50 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $112,542 - $131,134
-350 Reduced 0.24%
147,133 $53.8 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $59,296 - $67,574
-200 Reduced 0.14%
147,483 $47.7 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $83,619 - $98,181
-300 Reduced 0.2%
147,683 $47.9 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $9,387 - $11,666
-40 Reduced 0.03%
147,983 $42.4 Million
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $857,252 - $1.13 Million
-6,571 Reduced 4.25%
148,023 $25 Million
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $180,003 - $222,793
-1,512 Reduced 0.97%
154,594 $21.4 Million
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $116,115 - $143,818
1,086 Added 0.7%
156,106 $20.5 Million
Q3 2019

Nov 07, 2019

SELL
$106.79 - $116.16 $110,741 - $120,457
-1,037 Reduced 0.66%
155,020 $17.3 Million
Q1 2019

May 02, 2019

SELL
$111.31 - $131.02 $775,051 - $912,292
-6,963 Reduced 4.27%
156,057 $20.3 Million
Q4 2018

Jan 31, 2019

SELL
$105.9 - $118.64 $4,765 - $5,338
-45 Reduced 0.03%
163,020 $18.9 Million
Q2 2018

Aug 06, 2018

BUY
$75.7 - $86.88 $529,900 - $608,160
7,000 Added 4.49%
163,065 $13.9 Million
Q1 2018

May 08, 2018

BUY
$74.21 - $87.6 $89,051 - $105,120
1,200 Added 0.77%
156,065 $12.1 Million
Q4 2017

Feb 05, 2018

SELL
$81.94 - $87.89 $4,097 - $4,394
-50 Reduced 0.03%
154,865 $13.1 Million
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $11.9 Million - $13.3 Million
154,915
154,915 $13.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Blackhill Capital Inc Portfolio

Follow Blackhill Capital Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhill Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackhill Capital Inc with notifications on news.